市場調査レポート

商品コード

1619326

血液学診断薬市場規模、シェア、成長分析、製品別、検査別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

Hematology Diagnostics Market Size, Share, Growth Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy), By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 198 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

血液学診断薬の世界市場規模は2022年に78億米ドルと評価され、2023年の82億4,000万米ドルから2031年には128億5,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは5.7%で成長する見通しです。

血液学診断薬市場は、主に血液疾患の罹患率の増加とタイムリーで正確な診断ソリューションに対する需要の高まりにより、急速に発展しています。この分野は、血液検査のスピードと精度を向上させる自動血液分析装置やポイントオブケア検査装置などの技術的進歩に後押しされ、大きな成長の可能性を秘めています。ヘルスケアの専門家が早期発見とオーダーメイドの治療オプションを通じて患者の予後を改善しようとしていることから、この市場は拡大が見込まれています。しかし、コストや熟練者の必要性といった課題は依然として残っています。このようなハードルにもかかわらず、個別化医療へのシフトが進行しており、医療提供者や研究者が効果的な血液疾患管理を優先しているため、情勢は革新と成長の大きな機会を浮き彫りにしています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Sysmex Corporation（Japan）
Danaher Corporation（USA）
Abbott Laboratories（USA）
Siemens Healthineers（Germany）
Mindray（China）
Bio-Rad Laboratories（USA）
Nihon Kohden（Japan）
Boule Diagnostics（Sweden）
EKF Diagnostics（UK）
Horiba（Japan）
Roche Diagnostics（Switzerland）
Beckman Coulter（USA）
Diatron（Hungary）
Erba Mannheim（Germany）
Ortho Clinical Diagnostics（US）
Cellavision（Sweden）
Drucker Diagnostics（USA）
Heska Corporation（USA）
Neomedica（Germany）
Thermo Fisher Scientific（USA）

結論と推奨事項

Product Code: SQMIG35B2185

Global Hematology Diagnostics Market size was valued at USD 7.8 billion in 2022 and is poised to grow from USD 8.24 billion in 2023 to USD 12.85 billion by 2031, growing at a CAGR of 5.7% during the forecast period (2024-2031).

The hematology diagnostics market is rapidly evolving, primarily due to the increasing incidence of blood disorders and a growing demand for timely and precise diagnostic solutions. This sector offers considerable growth potential, fueled by technological advancements, including automated hematology analyzers and point-of-care testing devices that enhance the speed and accuracy of blood testing. As healthcare professionals seek to improve patient outcomes through early detection and tailored treatment options, the market is poised for expansion. However, challenges such as cost and the need for skilled personnel persist. Despite these hurdles, the ongoing shift towards personalized medicine highlights significant opportunities for innovation and growth within the hematology diagnostics landscape, as providers and researchers prioritize effective blood disorder management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Diagnostics Market Segmental Analysis

Global Hematology Diagnostics Market is segmented by product, test, end user and region. Based on product, the market is segmented into instrument and consumables. Based on test, the market is segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood count and others. Based on end user, the market is segmented into hospitals, diagnostics labs and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Diagnostics Market

The global hematology diagnostics market is significantly influenced by the rising incidence of blood disorders, including anemia, leukemia, and hemophilia. As these conditions become more prevalent, the need for precise and timely detection has surged, propelling the demand for advanced hematology diagnostic solutions. Healthcare providers are increasingly prioritizing early diagnosis and effective monitoring of blood-related ailments, leading to a greater consumption of specialized diagnostic tools and technologies. Consequently, this growing awareness and emphasis on blood health create substantial opportunities for industry players to innovate and expand their offerings within the hematology diagnostics sector, ultimately enhancing patient outcomes worldwide.

Restraints in the Global Hematology Diagnostics Market

The Global Hematology Diagnostics market faces several restraints, one significant barrier being the high expense linked to hematology diagnostic instruments and reagents. These elevated costs can hinder market expansion, as the substantial initial investment required, coupled with ongoing maintenance expenses, may deter healthcare facilities from adopting these technologies. This challenge is especially pronounced in economically constrained healthcare environments, where budget limitations restrict access to advanced diagnostic solutions. Consequently, the financial burden posed by these sophisticated instruments can significantly impact their utilization, ultimately stalling growth in the hematology diagnostics sector.

Market Trends of the Global Hematology Diagnostics Market

The Global Hematology Diagnostics market is witnessing a significant trend towards point-of-care testing, driven by the demand for rapid diagnosis and immediate treatment decisions directly at the patient's location. This shift is facilitated by advancements in portable and handheld hematology analyzers, which enhance the convenience and efficiency of testing in primary healthcare settings and emergency rooms. As healthcare providers seek to improve patient outcomes through timely interventions, the adoption of point-of-care solutions is expected to accelerate. This trend not only addresses the growing need for accessible diagnostics but also aligns with the broader movement towards personalized and immediate healthcare delivery.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Hematology Diagnostics Market Size by Product & CAGR (2024-2031)

Market Overview
Instrument
- Analyzer
- Flow Cytometers
Consumables
- Reagents
- Stains
- Others

Global Hematology Diagnostics Market Size by Test & CAGR (2024-2031)

Market Overview
Anemia
Hemoglobinopathy
Leukemia/Lymphoma Phenotyping
Hematology Pathophysiology
Complete Blood Count
Others

Global Hematology Diagnostics Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals
Diagnostics Labs
Others

Global Hematology Diagnostics Market Size & CAGR (2024-2031)

North America (Product, Test, End User)
- US
- Canada
Europe (Product, Test, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Test, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Test, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Test, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diatron (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Erba Mannheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellavision (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Drucker Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neomedica (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

血液学診断薬市場規模、シェア、成長分析、製品別、検査別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

Hematology Diagnostics Market Size, Share, Growth Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy), By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

血液学診断薬市場規模：製品別

血液学診断薬市場規模：検査別

血液学診断薬市場規模：エンドユーザー別

血液学診断薬市場規模：地域別